Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-21

Clinical Trial Update: A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis. [NA]

View source ↗

Summary

A clinical study is evaluating cannabigerol for efficacy in active rheumatoid arthritis; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabigerol (cannabigerol)

Snippet

Sponsor: Raphael Pharma | Conditions: Rheumatoid Arthritis, Inflammatory Disease | NA | Status: ACTIVE_NOT_RECRUITING